SQSTM1/p62 Promotes Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer by Regulating the AKT/AMPK/mTOR Signaling Pathway

• Published in: Frontiers in oncology Vol. 11; p. 638701
• Main Authors: Yu, Fangqin, Ma, Runsheng, Liu, Chenguang, Zhang, Lele, Feng, Kaixiang, Wang, Meiqi, Yin, Detao
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 15.04.2021
• Subjects: autophagy; Oncology; papillary thyroid cancer; proliferation; SQSTM1/p62; TPC-1; SQSTM1/p62; autophagy; proliferation; papillary thyroid cancer; TPC-1
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2021.638701

Thyroid cancer is one of the most common endocrine malignancies worldwide, and papillary thyroid cancer (PTC) is the most common pathologic type of thyroid cancer. SQSTM1/p62 activity mediates different biological functions. This study aimed to investigate the effect of SQSTM1/p62, a multifunctional receptor, on biological function and autophagy characteristics in the human PTC cell line TPC-1. A total of 105 primary PTC samples and matched adjacent normal thyroid tissue samples were obtained to evaluate the expression of p62 in clinical patients. A similar p62 expression pattern was found in PTC cell lines and normal human thyroid follicular epithelial cells. To evaluate the effect of SQSTM1/p62 on TPC-1 cells, we constructed the p62 knockout cell line p62-KO-TPC-1. Cell proliferation, cell cycle, and cell apoptosis were analyzed by colony formation tests, Cell Counting Kit-8 (CCK-8) assays and flow cytometry . TPC-1 and p62-KO-TPC-1 human PTC cell lines in the logarithmic growth phase were subcutaneously implanted into BALB/c nude mice to verify their proliferation effect . Furthermore, western blotting and immunohistochemistry (IHC) were used to detect the expression of AKT/AMPK/mTOR signaling pathway-related proteins. Overall, p62 expression was higher in tumor tissues than in normal tissues in 73 of 105 PTC patients (69.5%). The expression level of p62 in the PTC cell line was higher than that in the normal thyroid cell line. Our data indicated that , p62 deficiency could decrease the number of colonies, inhibit cell growth and the cell cycle, and induce apoptosis. Tumor xenograft experiments in BALB/c nude mice corroborated these findings. Moreover, the molecular mechanism was explored by western blotting, and we found that the AMPK/AKT/mTOR pathway was involved. The results indicate that p62 might mediate cell autophagy and apoptosis in TPC-1 cells the AMPK/AKT/mTOR pathway and could be used as a potential therapeutic approach for PTC.